Welcome to Dt& Investment

We bring the spirit of Ubuntu to the world of Venture Capital

About Us

I am what I am because you are

Our investment philosophy derives from the word UNBUNTU, "I am because you are".

Seungsuk (Duke) Lee, CEO of Dt&I, invested in Dt&C(parent company of Dt&I) with a venture fund and successfully got the company listed on the KOSDAQ in 2014.

After a successful IPO, chairman of Dt&C, Charlie Park established Dt&I so that more promising venture companies can be discovered and invested.

Dt&I since its inception continues to work hand-in-hand with venture companies to share market insights, entrepreneurial lessons of seasoned CEOs. All in hopes of ever growing and supporting venture companies leading to the creation of virtuous capital cycle, helping companies help companies.

Dt&I, we strive to be link that connect the venture ecosystem to global ambitions

Our Fund

₩ 303 Billion+ AUM

₩ 210 Billion+ Investments

29+ IPOs & Exits

6 Unicorns

Portfolio Highlights

PeopleBio Wadiz Philoptics DoubleU Games
cafe 24 ActRO PharmsVille Shinhwa Advance
cafe 24 Bonne REMED bridgebio therapeutics
InnoTherapy Kang Stem Biotech Neofect It's Skin
NEXTIN Cellid Global Tax Free RoyalCrow

2021

November

Smart Korea Untact Fund

June

DTN-KIS Growth 2021 Fund

2020

August

TIPS Partner

July

DTN-KIS Unicorn Venture Fund (₩10.3B)

June

The Next Unicorn Fund (₩54.8B)

February

Achieve Accelerator license

2018

December

Korea VC Awards 2018, Rising Star

November

DTNI Startup Innovation Fund (₩58.8B)

August

NHC-DTNI Agrifood General Venture Fund Ⅱ (₩20B)

2017

September

DTNI-Soft Industry Promotion Fund (₩15B)

August

NHC-DTNI Agrifood ABC Venture Fund Ι (₩22B)

2016

August

Growth Companies Venture Fund I (₩11.3B)

March

DTNI-Startup Creative Growth Fund (₩11.5B)

January

DTNI-JEONNAM CREATIVE ECONOMY INNOVATION FUND (₩11.5B)

2015

December

DTNI-KVIC PANGYO CREATIVE ECONOMY VALLY FUND (₩22.7B)

October

DTNI-AGRITECH Venture Fund (₩12B)

April

DTNI founded as a venture capital (₩10B)

Portfolio

We are stewards of great privilege to work on behalf of sovereign wealth funds and institutional investors to continue to grow and foster the venture ecosystem. Together we envision a better world, together we can be the catalyst that changes the world.

  • All
  • Bio/Healthcare
  • LifeStyle
  • ICT/Fintech/Game
  • Oversees
Wadiz
cafe 24
cafe 24
Cellid
Bonne
REMED
PeopleBio
InnoTherapy
ActRO
neofect
PRND
DOUBLEU Games
WECOOK
NEXTIN
AIM
PROPZY
LOZI
Royalcrow
Team Fresh
MEATBOX
CellMEAT
mfort
Egnis
Dealicious
Barley Platform

Team

Dt& Investment team strives to be a link that connect the venture ecosystem to global ambitions.
Together as partners we are here because you are.

Investment Group

Seungsuk Lee

Lee Seungsuk

Chief Executive Officer
Honor
2018 Minister's Award (Ministry of SMEs and Startups)
Major Investment field
Lifestyle Business
Major Investment Company
IPO (18 companies), Dt&C, Cafe24, Actro, ADP engineering, Nextin etc.
Major career
SJ Investment Partners, m-Venture
Mineui Jeong

Jeong Mineui

Chief Investment Officer
Honor
2019 Minister's Award (Ministry of SMEs and Startups)
Major Investment field
Bio, Healthcare
Major Investment Company
IPO (10 companies) - Sillajen, Celled, Bonne, Kangstem Biotech, DoubleU Games, Peoplebio, Exocobio, etc.
Major career
KTB Network, ES Investor Corp
Jaeman Han

Han Jaeman

Partner
Honor
Minister's Award (Ministry of Food, Agriculture, Forestry and Fisheries)
Major Investment field
Cosmetics, Health Functional Food, Beauty
Major Investment Company
IPO (7 companies) - YMT, Peptron, Inno Therapy, Pharms ville, Philoptics, Raphas, NBT, etc.
Major career
ID-Ventures, UQI Partners, Shinhan Bank
Dongkun Cho

Cho Dongkun

Partner
Honor
Minister's Award (Ministry of Science, ICT and Future Planning)
Major Investment field
Fintech, ICT Service, Foreign Investment
Major Investment Company
IPO (6 companies) – Peptron, SGA Solutions, Endochoice, Neofect, Remed, SGA Systems etc.
Major career
m-Venture, KT
Hyunsun Jang

Jang Hyunsun

Team Manager
Major Investment field
Bio, Healthcare
Major career
Daewoong Pharmaceutical, Boryung Pharmaceutical
Sunghan Lee

Lee Sunghan

Manager
Major Investment field
ICT, Mobility, AI
Major career
Samsung C&T, Hyundai MOBIS
Myungjin Kim

Kim Myungjin

Manager
Major Investment field
Bio, Healthcare
Major career
AMsciences, CAUH(Chung-ang University Hospital), SNUH(Seoul National University Hospital)
Sungho Park

Park Sungho

Manager
Major Investment field
SW, AI, TMT
Major career
DZS(Dasan Zhone Solutions Inc.), StartupTree
Sangcheon Park

Park Sangcheon

Manager
Major Investment field
AgriTech, Lifestyle, ICT Convergence
Major career
LG Electronics
Soonwoo Lee

Lee Soonwoo

Associate
Major Investment field
ICT Service, Foreign Investment
Major Investment Company
I-Solar Energy

Management Support Group

Hyunsook Lee

Lee Hyunsook

Director
Major Responsibilities
Compliance, Risk Management, Accounting, Fund Administration
Yoonjung Baik

Baik Yoonjung

Senior Manager
Major Responsibilities
Accounting, Fund Administration
Rayoung Kim

Kim Rayoung

Manager
Major Responsibilities
Accounting, Fund Administration
Jiseon Kim

Kim Jiseon

Associate
Major Responsibilities
Accounting, Fund Administration
Hyojin Ko

Ko Hyojin

Associate
Major Responsibilities
Accounting, Fund Administration

Contact

도로명 주소:

06180 서울시 강남구 테헤란로 516, 5층 (대치동, 정헌빌딩)

지번 주소:

06180 서울시 강남구 대치동 944-1, 5층 (대치동, 정헌빌딩)

Road Name Address:

5F, Junghun Building, 516, Teheran-ro, Gangnam-gu, Seoul, Korea (06180)

Land-Lot Based Address:

5F, Junghun Building, 944-1, Daechi-dong, Gangnam-gu, Seoul, Korea (06180)

Notice

  • 『주식회사의 외부감사에 관한 법률』 제4조 및 동법 시행령 제3조의2에 의거하여 아래와 같이 외부감사인을 선임하였음을 공고합니다.  외부감사인 : 대영회계법인  감사대상기간 : 2019년 1월 1일 ~ 2019년 12월 31일  선임일 : 2019년 2월 14일 2019년 2월 15일 ㈜디티앤인베스트먼트 대 표 이 사 이 승 석

  • 『주식회사의 외부감사에 관한 법률』 제4조 및 동법 시행령 제3조의2에 의거하여 아래와 같이 외부감사인을 선임하였음을 공고합니다.  외부감사인 : 한미회계법인  감사대상기간 : 2018년 1월 1일 ~ 2018년 12월 31일  선임일 : 2018년 4월 30일 2018년 4월 30일 ㈜디티앤인베스트먼트 대 표 이 사 이 승 석